(Q39879394)

15 September 2017

ERK and PI3K regulate different aspects of the epithelial to mesenchymal transition of mammary tumor cells induced by truncated MUC1. (English)

1 reference

15 September 2017

1

Galit Horn

1 reference

15 September 2017

Nechama I. Smorodinsky

series ordinal

4

object named as

Nechama I Smorodinsky

1 reference

15 September 2017

Avital Gaziel

2

1 reference

15 September 2017

Daniel H Wreschner

series ordinal

3

1 reference

15 September 2017

Marcelo Ehrlich

series ordinal

5

1 reference

15 September 2017

language of work or name

English

0 references

publication date

23 February 2009

1 reference

Experimental Cell Research

15 September 2017

1 reference

15 September 2017

315

1 reference

15 September 2017

8

1 reference

15 September 2017

1490-1504

1 reference

The epithelial-mesenchymal transition: new insights in signaling, development, and disease

15 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Epithelial-mesenchymal transitions in development and pathologies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Cellular and molecular mechanisms of fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Epithelial-mesenchymal transitions: twist in development and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Molecular requirements for epithelial-mesenchymal transition during tumor progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Production and characterization of monoclonal antibodies identifying breast tumor-associated antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Effective immunotherapy of cancer in MUC1-transgenic mice using clonal cytotoxic T lymphocytes directed against an immunodominant MUC1 epitope.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

The MUC1 SEA module is a self-cleaving domain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Autoproteolysis coupled to protein folding in the SEA domain of the membrane-bound MUC1 mucin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Contribution of membrane mucins to tumor progression through modulation of cellular growth signaling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

The cytoplasmic tail of MUC1: a very busy place

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Interaction of human MUC1 and beta-catenin is regulated by Lck and ZAP-70 in activated Jurkat T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Cell surface-associated mucins in signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

MUC1, the renaissance molecule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Does a novel form of the breast cancer marker protein, MUC1, act as a receptor molecule that modulates signal transduction?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Actin-rich spherical extrusion induced in okadaic acid-treated K562 cells by crosslinking of membrane microdomains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

MUC1 alters oncogenic events and transcription in human breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

The MUC1 and galectin-3 oncoproteins function in a microRNA-dependent regulatory loop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

MUC1/X protein immunization enhances cDNA immunization in generating anti-MUC1 alpha/beta junction antibodies that target malignant cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Detection of a secreted MUC1/SEC protein by MUC1 isoform specific monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Preferential expression of novel MUC1 tumor antigen isoforms in human epithelial tumors and their tumor-potentiating function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

A unique mucin immunoenhancing peptide with antitumor properties.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

MUC1/sec-expressing tumors are rejected in vivo by a T cell-dependent mechanism and secrete high levels of CCL2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Antitumor effects of Mucin 1/sec involves the modulation of urokinase-type plasminogen activator and signal transducer and activator of transcription 1 expression in tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Novel MUC1 splice variants contribute to mucin overexpression in CFTR-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Sp1 is required for transforming growth factor-beta-induced mesenchymal transition and migration in pancreatic cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Epithelial-mesenchymal transition in cervical cancer: correlation with tumor progression, epidermal growth factor receptor overexpression, and snail up-regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Structure and function of the cell surface (tethered) mucins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Matrix metalloproteinases stimulate epithelial-mesenchymal transition during tumor development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Epithelial-mesenchymal transition (EMT) and activated extracellular signal-regulated kinase (p-Erk) in surgically resected pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Snail is required for transforming growth factor-beta-induced epithelial-mesenchymal transition by activating PI3 kinase/Akt signal pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Epithelial mesenchymal transition traits in human breast cancer cell lines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Restoration of E-cadherin cell-cell junctions requires both expression of E-cadherin and suppression of ERK MAP kinase activation in Ras-transformed breast epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Breast tumor cell lines from pleural effusions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Establishment and characterization of a cell line of human breast carcinoma origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Downregulation of MMP-9 in ERK-mutated stable transfectants inhibits glioma invasion in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Regulation of tumor cell motility by ERK mitogen-activated protein kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Tyrosines in the MUC1 cytoplasmic tail modulate transcription via the extracellular signal-regulated kinase 1/2 and nuclear factor-kappaB pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

CA27.29: a valuable marker for breast cancer management. A confirmatory multicentric study on 603 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Overexpression and altered glycosylation of MUC1 in malignant mesothelioma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

Recombinant tumor-associated MUC1 glycoprotein impairs the differentiation and function of dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

The MAP kinase pathway is required for entry into mitosis and cell survival.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

The MEK/ERK cascade: from signaling specificity to diverse functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

p44 mitogen-activated protein kinase (extracellular signal-regulated kinase 1)-dependent signaling contributes to epithelial skin carcinogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.02.011

10.1016/J.YEXCR.2009.02.011

7 January 2021

Identifiers

DOI

1 reference

15 September 2017

1 reference